Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative nesiritide in cardiac surgery patients with elevated NT-proBNP
ChiCTR2200060581Phase 4Not yet recruiting
- Sponsor
- Shandong Provincial Hospital Affiliated to Shandong First Medical University
- Start
- Jul 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of nesiritide in cardiac morbidity (2 arms), sponsored by Shandong Provincial Hospital Affiliated to Shandong First Medical University. Primary endpoint: NT-proBNP. Planned start Jul 2022; status: not yet recruiting.
02
Drugs
nesiritide
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on ChiCTR2200060581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200060581.